The ROE (Return on Equity) of Nexus Biopharma Inc (NEXS) is 47.19%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2017-02-28 | 47.19% |
| 2015-12-31 | 48.99% |
| 2014-12-31 | 3.21% |
| 2013-12-31 | 36.19% |
| 2012-12-31 | 34.86% |
| 2011-12-31 | 100.00% |
| 2010-12-31 | -300.00% |
| 2009-12-31 | -200.00% |
| 2008-12-31 | -40.00% |